Venus Concept Price to Book Ratio 2016-2025 | VERO
Historical price to book ratio values for Venus Concept (VERO) over the last 10 years. The current price to book ratio for Venus Concept as of January 16, 2026 is 3.64.
| Venus Concept Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-16 | 8.00 | 4.75 | |
| 2025-09-30 | 2.30 | $1.69 | 1.36 |
| 2025-06-30 | 2.37 | $1.49 | 1.59 |
| 2025-03-31 | 2.79 | $3.85 | 0.73 |
| 2024-12-31 | 4.14 | $4.00 | 1.03 |
| 2024-09-30 | 6.71 | $16.12 | 0.42 |
| 2024-06-30 | 8.61 | $6.62 | 1.30 |
| 2024-03-31 | 7.60 | $-37.93 | -0.20 |
| 2023-12-31 | 12.98 | $-24.36 | -0.53 |
| 2023-09-30 | 21.56 | $-22.64 | -0.95 |
| 2023-06-30 | 23.10 | $-11.03 | -2.09 |
| 2023-03-31 | 36.17 | $-0.42 | -85.58 |
| 2022-12-31 | 52.80 | $18.62 | 2.83 |
| 2022-09-30 | 72.60 | $25.18 | 2.88 |
| 2022-06-30 | 76.53 | $59.92 | 1.28 |
| 2022-03-31 | 235.95 | $86.14 | 2.74 |
| 2021-12-31 | 280.50 | $107.23 | 2.62 |
| 2021-09-30 | 414.15 | $87.62 | 4.73 |
| 2021-06-30 | 513.15 | $112.25 | 4.57 |
| 2021-03-31 | 387.75 | $109.66 | 3.54 |
| 2020-12-31 | 285.45 | $134.78 | 2.12 |
| 2020-09-30 | 382.80 | $147.89 | 2.59 |
| 2020-06-30 | 575.85 | $167.02 | 3.45 |
| 2020-03-31 | 585.75 | $238.60 | 2.45 |
| 2019-12-31 | 775.50 | $440.87 | 1.76 |
| 2019-09-30 | 1608.50 | $-1,317.06 | -1.22 |
| 2019-06-30 | 1509.75 | $-785.71 | -1.92 |
| 2019-03-31 | 1460.25 | $-332.03 | -4.40 |
| 2018-12-31 | 1078.11 | $1,259.73 | 0.86 |
| 2018-09-30 | 7177.51 | $566.16 | 12.68 |
| 2018-06-30 | 8588.27 | $51.17 | 167.83 |
| 2018-03-31 | 15419.30 | $518.29 | 29.75 |
| 2017-12-31 | 11385.00 | $1,127.36 | 10.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.011B | $0.065B |
| Venus Concept Inc. designs and develops medical aesthetic equipment. The company's product portfolio consists of aesthetic device platforms, including Venus Versa(TM), Venus Legacy(TM), Venus Velocity(TM), Venus Fiore(TM), Venus Viva(TM), Venus Freeze Plus(TM) and Venus Bliss(TM). It also provides NeoGraft(R), an automated hair restoration system; ARTAS(R) and ARTAS Ix(TM) Robotic Hair Restoration Systems. Venus Concept Inc., formerly known as Restoration Robotics Inc., is based in TORONTO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| IDEXX Laboratories (IDXX) | United States | $57.123B | 56.73 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Masimo (MASI) | United States | $7.630B | 24.45 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.667B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Alcon (ALC) | Switzerland | $0.000B | 26.33 |